Repligen RGEN
NASDAQ RGEN
$181.13 +0.84 (+0.47%)
At close: Aug 21, 2026 · 4:00 PM EDT

Repligen (RGEN) Non-Current Deferred Tax Liability (2011 - 2026)

Repligen (RGEN) posted quarterly Non-Current Deferred Tax Liability of $16.8 million for Q2 2026, down 28.07% year-over-year from $23.3 million in Q2 2025, and up 11.72% quarter-over-quarter from $15.0 million in Q1 2026.

Repligen (RGEN) Non-Current Deferred Tax Liability (2011 - 2026) Analysis & Trends

Repligen (RGEN) has reported Non-Current Deferred Tax Liability for 15 consecutive years, with $16.8 million the latest figure, recorded in Q2 2026.

  • In Q2 2026, Non-Current Deferred Tax Liability fell 28.07% year-over-year to $16.8 million; the TTM figure through Jun 2026 stood at $16.8 million (down 28.07% YoY), while the FY2025 annual figure was $22.5 million, down 1.23% from the prior year.
  • Non-Current Deferred Tax Liability improved to $16.8 million in Q2 2026 per RGEN's latest filing, from $15.0 million in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $39.3 million in Q4 2023 and bottomed at $14.5 million in Q3 2023.
  • Historically, Non-Current Deferred Tax Liability has averaged $24.6 million across 5 years, with a median of $23.2 million in 2022.
  • On a YoY basis, Non-Current Deferred Tax Liability climbed as much as 131.93% in 2024 and fell as far as 42.08% in 2024.
  • Repligen's Non-Current Deferred Tax Liability stood at $23.0 million in 2022, then jumped by 70.97% to $39.3 million in 2023, then plunged by 42.08% to $22.8 million in 2024, then slipped by 1.23% to $22.5 million in 2025, then fell by 25.42% to $16.8 million in 2026.
  • Business Quant data shows RGEN's Non-Current Deferred Tax Liability at $16.8 million in Q2 2026, $15.0 million in Q1 2026, and $22.5 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn
10 Repligen 10.25 Bn 9.24 Bn 110.04 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 16.78 Mn
Jun 30, 2026 16.78 Mn
Mar 31, 2026 15.02 Mn
Mar 31, 2026 15.02 Mn
Dec 31, 2025 22.50 Mn
Dec 31, 2025 22.50 Mn
Sep 30, 2025 20.14 Mn
Sep 30, 2025 20.14 Mn
Jun 30, 2025 23.33 Mn
Jun 30, 2025 23.33 Mn
Mar 31, 2025 24.14 Mn
Mar 31, 2025 24.14 Mn
Dec 31, 2024 22.78 Mn
Dec 31, 2024 22.78 Mn
Sep 30, 2024 33.69 Mn
Sep 30, 2024 33.69 Mn
Jun 30, 2024 34.04 Mn
Jun 30, 2024 34.04 Mn
Mar 31, 2024 36.81 Mn
Mar 31, 2024 36.81 Mn